CS215016B2 - Method of making the new derivatives of 6-methoxy-2-acetylnaphtalenoxime - Google Patents
Method of making the new derivatives of 6-methoxy-2-acetylnaphtalenoxime Download PDFInfo
- Publication number
- CS215016B2 CS215016B2 CS795313A CS531379A CS215016B2 CS 215016 B2 CS215016 B2 CS 215016B2 CS 795313 A CS795313 A CS 795313A CS 531379 A CS531379 A CS 531379A CS 215016 B2 CS215016 B2 CS 215016B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- снз
- calculated
- methoxy
- found
- derivatives
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- FKUMAWUBPURONA-UHFFFAOYSA-N n-[1-(6-methoxynaphthalen-2-yl)ethylidene]hydroxylamine Chemical class C1=C(C(C)=NO)C=CC2=CC(OC)=CC=C21 FKUMAWUBPURONA-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- -1 6-methoxy-2-acetylnaphthalenoxy Chemical class 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 210000003815 abdominal wall Anatomy 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 235000012431 wafers Nutrition 0.000 description 3
- BJKZQNPIHGBLIV-UHFFFAOYSA-N 2-[1-(6-methoxynaphthalen-2-yl)ethylideneamino]oxy-n,n-dimethylethanamine Chemical compound C1=C(C(C)=NOCCN(C)C)C=CC2=CC(OC)=CC=C21 BJKZQNPIHGBLIV-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CWKVFRNCODQPDB-UHFFFAOYSA-N 1-(2-aminoethylamino)propan-2-ol Chemical compound CC(O)CNCCN CWKVFRNCODQPDB-UHFFFAOYSA-N 0.000 description 1
- GUWMQEUWBPJTNQ-UHFFFAOYSA-N 1-(6-methoxynaphthalen-2-yl)-n-(2-pyrrolidin-1-ylethoxy)ethanimine;hydrochloride Chemical compound Cl.C1=CC2=CC(OC)=CC=C2C=C1C(C)=NOCCN1CCCC1 GUWMQEUWBPJTNQ-UHFFFAOYSA-N 0.000 description 1
- VKPPFDPXZWFDFA-UHFFFAOYSA-N 2-chloroethanamine Chemical class NCCCl VKPPFDPXZWFDFA-UHFFFAOYSA-N 0.000 description 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229920003084 Avicel® PH-102 Polymers 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241001539019 Monolene Species 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- ZEHGKSPCAMLJDC-UHFFFAOYSA-M acetylcholine bromide Chemical compound [Br-].CC(=O)OCC[N+](C)(C)C ZEHGKSPCAMLJDC-UHFFFAOYSA-M 0.000 description 1
- 229940080018 acetylcholine injection Drugs 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- KBNIKBYJSGHJOF-UHFFFAOYSA-N n,n-diethyl-2-[1-(6-methoxynaphthalen-2-yl)ethylideneamino]oxyethanamine;hydrochloride Chemical compound Cl.C1=C(OC)C=CC2=CC(C(C)=NOCCN(CC)CC)=CC=C21 KBNIKBYJSGHJOF-UHFFFAOYSA-N 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7822836A FR2432506A1 (fr) | 1978-08-02 | 1978-08-02 | Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS215016B2 true CS215016B2 (en) | 1982-06-25 |
Family
ID=9211492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS795313A CS215016B2 (en) | 1978-08-02 | 1979-08-01 | Method of making the new derivatives of 6-methoxy-2-acetylnaphtalenoxime |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4267334A (fi) |
| JP (1) | JPS5555155A (fi) |
| AR (1) | AR221502A1 (fi) |
| AT (1) | AT367744B (fi) |
| BE (1) | BE878019A (fi) |
| BG (1) | BG36198A3 (fi) |
| CA (1) | CA1128519A (fi) |
| CH (1) | CH641773A5 (fi) |
| CS (1) | CS215016B2 (fi) |
| DD (1) | DD145266A5 (fi) |
| DE (1) | DE2931319A1 (fi) |
| EG (1) | EG14368A (fi) |
| ES (1) | ES481855A1 (fi) |
| FI (1) | FI70012C (fi) |
| FR (1) | FR2432506A1 (fi) |
| GB (1) | GB2045743B (fi) |
| GR (1) | GR69826B (fi) |
| IL (1) | IL57931A (fi) |
| NL (1) | NL7905939A (fi) |
| PL (1) | PL116462B1 (fi) |
| PT (1) | PT70005A (fi) |
| RO (1) | RO77339A (fi) |
| SE (1) | SE446530B (fi) |
| SU (1) | SU784763A3 (fi) |
| YU (1) | YU41874B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58156006U (ja) * | 1982-04-13 | 1983-10-18 | 日本電気ホームエレクトロニクス株式会社 | 車輌室内換気装置 |
| JPS61192912U (fi) * | 1985-05-25 | 1986-12-01 | ||
| JPH0525285Y2 (fi) * | 1987-01-12 | 1993-06-25 | ||
| JPS63173814U (fi) * | 1987-05-02 | 1988-11-11 | ||
| DE602005025521D1 (de) * | 2004-10-26 | 2011-02-03 | Sigma Aldrich Co | Synthese von aminosäure-n-carboxyanhydriden |
| GB2435830A (en) * | 2006-03-09 | 2007-09-12 | Del Dr Esteve S A Spain Lab | Oxime ether compounds for the treatment of conditions associated with food uptake |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3963778A (en) * | 1965-11-10 | 1976-06-15 | Bayer Aktiengesellschaft | Basic oximes and their preparation |
| US3937841A (en) * | 1967-04-05 | 1976-02-10 | U.S. Philips Corporation | Treatment of depression |
-
1978
- 1978-08-02 FR FR7822836A patent/FR2432506A1/fr active Granted
-
1979
- 1979-06-06 ES ES481855A patent/ES481855A1/es not_active Expired
- 1979-07-20 US US06/059,249 patent/US4267334A/en not_active Expired - Lifetime
- 1979-07-26 YU YU1821/79A patent/YU41874B/xx unknown
- 1979-07-30 DD DD79214687A patent/DD145266A5/de not_active IP Right Cessation
- 1979-07-31 CH CH705179A patent/CH641773A5/fr not_active IP Right Cessation
- 1979-07-31 IL IL57931A patent/IL57931A/xx not_active IP Right Cessation
- 1979-07-31 GR GR59743A patent/GR69826B/el unknown
- 1979-07-31 PT PT70005A patent/PT70005A/pt unknown
- 1979-08-01 EG EG466/79A patent/EG14368A/xx active
- 1979-08-01 CS CS795313A patent/CS215016B2/cs unknown
- 1979-08-01 CA CA333,015A patent/CA1128519A/fr not_active Expired
- 1979-08-01 PL PL1979217508A patent/PL116462B1/pl unknown
- 1979-08-01 BE BE0/196559A patent/BE878019A/fr not_active IP Right Cessation
- 1979-08-01 BG BG044522A patent/BG36198A3/xx not_active Expired
- 1979-08-01 RO RO7998336A patent/RO77339A/ro unknown
- 1979-08-01 DE DE19792931319 patent/DE2931319A1/de not_active Ceased
- 1979-08-01 JP JP9860079A patent/JPS5555155A/ja active Granted
- 1979-08-01 SE SE7906509A patent/SE446530B/sv not_active IP Right Cessation
- 1979-08-01 NL NL7905939A patent/NL7905939A/nl not_active Application Discontinuation
- 1979-08-01 AT AT0528779A patent/AT367744B/de not_active IP Right Cessation
- 1979-08-02 GB GB7926940A patent/GB2045743B/en not_active Expired
- 1979-08-02 FI FI792414A patent/FI70012C/fi not_active IP Right Cessation
- 1979-08-02 AR AR277580A patent/AR221502A1/es active
- 1979-08-02 SU SU792792753A patent/SU784763A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5555155A (en) | 1980-04-22 |
| PL217508A1 (fi) | 1980-03-24 |
| FI70012C (fi) | 1986-09-12 |
| FI792414A (fi) | 1980-02-03 |
| AR221502A1 (es) | 1981-02-13 |
| DD145266A5 (de) | 1980-12-03 |
| AT367744B (de) | 1982-07-26 |
| EG14368A (en) | 1984-09-30 |
| FI70012B (fi) | 1986-01-31 |
| CA1128519A (fr) | 1982-07-27 |
| ES481855A1 (es) | 1980-02-16 |
| GB2045743B (en) | 1982-09-02 |
| IL57931A (en) | 1982-08-31 |
| YU182179A (en) | 1983-04-30 |
| SE7906509L (sv) | 1980-02-03 |
| GR69826B (fi) | 1982-07-13 |
| SE446530B (sv) | 1986-09-22 |
| FR2432506B1 (fi) | 1981-07-24 |
| CH641773A5 (fr) | 1984-03-15 |
| BG36198A3 (en) | 1984-09-14 |
| GB2045743A (en) | 1980-11-05 |
| SU784763A3 (ru) | 1980-11-30 |
| YU41874B (en) | 1988-02-29 |
| DE2931319A1 (de) | 1980-02-14 |
| BE878019A (fr) | 1980-02-01 |
| ATA528779A (de) | 1981-12-15 |
| NL7905939A (nl) | 1980-02-05 |
| PL116462B1 (en) | 1981-06-30 |
| US4267334A (en) | 1981-05-12 |
| IL57931A0 (en) | 1979-11-30 |
| RO77339A (ro) | 1981-08-17 |
| PT70005A (fr) | 1979-08-01 |
| FR2432506A1 (fr) | 1980-02-29 |
| JPS5748107B2 (fi) | 1982-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3687965A (en) | Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation | |
| US6294517B1 (en) | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use | |
| IE53274B1 (en) | Chemical compounds derived from cyclobutene | |
| PT85628B (pt) | Processo para a preparacao de derivados de piperidina | |
| EP0275696B1 (en) | Piperidine derivatives | |
| US6887876B2 (en) | Benzamidine derivatives | |
| US7576105B2 (en) | Benzyl substituted (piperidin-4-yl)aminobenzamido derivatives | |
| CS215016B2 (en) | Method of making the new derivatives of 6-methoxy-2-acetylnaphtalenoxime | |
| US4499286A (en) | Derivatives of thienylacetic acid amides and their pharmaceutically acceptable acid salts and a process for the preparation thereof | |
| JPH089580B2 (ja) | アミノアルコ−ル、その製造法およびその用途 | |
| KR900004148B1 (ko) | 피롤로[1,2-a][4,1]벤즈옥사제핀 유도체 | |
| CZ298219B6 (cs) | Derivát benzamidu, jeho pouzití a lécivo s jeho obsahem | |
| US3423512A (en) | Treatment of emesis in mammals with substituted methylenedioxy benzamides | |
| PT87031B (pt) | Processo de preparacao de compostos de 4-fenilpiperidina e de composicoes farmaceuticas que os contem | |
| CZ280228B6 (cs) | (Endo)-N//(8-methyl-8-azabicyklo/3.2.1/oktan-3-yl)-amino/-karbonyl/-2-(cyklopropylmethoxy)benzamid, způsob výroby a farmaceutické prostředky s jeho obsahem | |
| US3700663A (en) | Dibenzothiazepine ethers | |
| PT86424B (pt) | Processo para a preparacao de tetra-hidropirido-indoles substituidos | |
| CS216651B2 (en) | Method of making the p-chloracetophenonoxine derivatives | |
| US5508401A (en) | Substituted dibenzo[a,d]cycloheptene NMDA antagonists | |
| US4205074A (en) | Anti-spasmodic substituted quinolizidine and indolizidine compounds | |
| GB1565767A (en) | Substituted 1,2,4 - triazines processes for their preparation and pharmaceutical compositions containing them | |
| KR950002830B1 (ko) | 아미노알코홀 및 이를 함유하는 약학적 조성물 | |
| PT94298B (pt) | Processo para a preparacao de derivados de 4, 5, 5a, 6-tetra-hidro-3h-isoxazolo{5,4,3-k1}acridinas e de composicoes farmaceuticas que os contem | |
| US4124716A (en) | Process for the treatment of spasmodic conditions in humans | |
| GB1596221A (en) | 4-tertiary-butyl-3'-chlorodiphenylamine derivatives with anti-histamine action and a process for the preparation thereof |